Grant: Operating Grant: Programmatic Grants in Food and Health - LOI
University of Saskatchewan
$10,000.00
Harvesting the anti-inflammatory properties of nutritional portfolios for intestinal health.
FY 2012-13
Summary
Many Canadians have been affected by chronic intestinal disease(s). These diseases cost Canadians millions of dollars in costs related to health care and loss of productivity. Progress relating to the treatment of these conditions has been slow. Inflammatory bowel disease (IBD) affects people at a young age and results in life-long suffering. The disease is thought to arise as a result of a combination of a person's genetics as well as environmental factors. There is no cure for this disease. Therapies proven to be effective modify the immune system and put patients at risk of developing infections and cancers. Bacteria that live in the gut play a role in the development of IBD and an important role in the digestion and metabolism of nutrients. Bacteria interact with nutrients in the intestine and to turn them into compounds that might affect the gut as well as the entire body. Flax contains components that have beneficial anti-inflammatory, anti-oxidant and anti-cancer properties. In fact, there are components of flax that are metabolized by intestinal bacteria to forms that have been shown to be very beneficial for many disease states. Canada is one of the world leaders in Flax development accounting for at least 35 percent of the world's supply. Agricultural scientists in Saskatchewan have developed methods for extracting specific beneficial components of Flax. This program of research proposes bringing together researchers and clinicians from diverse disciplines within Saskatchewan and across Canada in order to study these nutritional compounds alone and in combination (also known as portfolios) in animals and in humans with chronic intestinal inflammatory conditions. This research will provide much needed answers to many questions including: 1) what affects do these portfolios have on the gut and the inflammatory response in animals and humans and 2) which and how much of these portfolios should humans be eating to treat or prevent intestinal disease.
Department
Program
Operating Grant: Programmatic Grants in Food and Health - LOI
Recipient
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
262617
Name
Jones Jennifer L
Region
Saskatchewan
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Operating Grant: Programmatic Grants in Food and Health - LOI
Projecttitle
Harvesting the anti-inflammatory properties of nutritional portfolios for intestinal health.
Programtype2
Operating Grants
Orgnameinp2
University of Saskatchewan
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Operating Grant: Programmatic Grants in Food and Health - LOI
Keyworddelim
Cyclopeptides; Fiber; Flax; Inflammation; Intestinal Health; Lignans; Nutrition
Abstract
Many Canadians have been affected by chronic intestinal disease(s). These diseases cost Canadians millions of dollars in costs related to health care and loss of productivity. Progress relating to the treatment of these conditions has been slow. Inflammatory bowel disease (IBD) affects people at a young age and results in life-long suffering. The disease is thought to arise as a result of a combination of a person's genetics as well as environmental factors. There is no cure for this disease. Therapies proven to be effective modify the immune system and put patients at risk of developing infections and cancers. Bacteria that live in the gut play a role in the development of IBD and an important role in the digestion and metabolism of nutrients. Bacteria interact with nutrients in the intestine and to turn them into compounds that might affect the gut as well as the entire body. Flax contains components that have beneficial anti-inflammatory, anti-oxidant and anti-cancer properties. In fact, there are components of flax that are metabolized by intestinal bacteria to forms that have been shown to be very beneficial for many disease states. Canada is one of the world leaders in Flax development accounting for at least 35 percent of the world's supply. Agricultural scientists in Saskatchewan have developed methods for extracting specific beneficial components of Flax. This program of research proposes bringing together researchers and clinicians from diverse disciplines within Saskatchewan and across Canada in order to study these nutritional compounds alone and in combination (also known as portfolios) in animals and in humans with chronic intestinal inflammatory conditions. This research will provide much needed answers to many questions including: 1) what affects do these portfolios have on the gut and the inflammatory response in animals and humans and 2) which and how much of these portfolios should humans be eating to treat or prevent intestinal disease.
Competitiondate
201205
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jones, Jennifer L; Reaney, Martin J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $10,000~ $0~